Although the relevance of CICD for the treatment of lymphoma patients remains to be investigated, the high expression of several AP1 transcription factors in DLBCL patient tissues across the different subtypes supports a potential role of AP1 in cell death induced by mitochondrial perturbations. This evidence concerns the gene FOS and lymphoma.